tradingkey.logo
tradingkey.logo

Retractable Technologies Inc

RVP
0.670USD
-0.013-1.86%
Market hours ETQuotes delayed by 15 min
16.97MMarket Cap
LossP/E TTM

Retractable Technologies Inc

0.670
-0.013-1.86%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Retractable Technologies Inc

Currency: USD Updated: 2026-03-27

Key Insights

Retractable Technologies Inc's fundamentals are relatively stable, with low ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 146 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Retractable Technologies Inc's Score

Industry at a Glance

Industry Ranking
146 / 208
Overall Ranking
416 / 4542
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Retractable Technologies Inc Highlights

StrengthsRisks
Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.
Growing
The company is in a growing phase, with the latest annual income totaling USD 38.27M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 38.27M.
Overvalued
The company’s latest PE is -1.57, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 2.46M shares, increasing 5.11% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 447.01K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.17.

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Retractable Technologies Inc is 6.02, ranking 173 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 9.44M, representing a year-over-year increase of 4.03%, while its net profit experienced a year-over-year increase of 164.79%.

Score

Industry at a Glance

Previous score
6.02
Change
0

Financials

5.29

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

3.70

Operational Efficiency

7.14

Growth Potential

6.88

Shareholder Returns

7.10

Retractable Technologies Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Retractable Technologies Inc is 7.47, ranking 81 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -1.57, which is -979.14% below the recent high of 13.78 and -2373.82% above the recent low of -38.78.

Score

Industry at a Glance

Previous score
7.47
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 146/208
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

No earnings forecast score is currently available for Retractable Technologies Inc. The Healthcare Equipment & Supplies industry's average is 7.78.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Retractable Technologies Inc is 6.64, ranking 92 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 0.73 and the support level at 0.62, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.83
Change
-0.19

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.003
Neutral
RSI(14)
42.635
Neutral
STOCH(KDJ)(9,3,3)
30.422
Sell
ATR(14)
0.044
Low Volatility
CCI(14)
-204.056
Oversold
Williams %R
86.215
Oversold
TRIX(12,20)
0.163
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
0.702
Sell
MA10
0.703
Sell
MA20
0.698
Sell
MA50
0.691
Sell
MA100
0.751
Sell
MA200
0.770
Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Retractable Technologies Inc is 3.00, ranking 135 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 8.20%, representing a quarter-over-quarter increase of 17.16%. The largest institutional shareholder is The Vanguard, holding a total of 672.81K shares, representing 2.25% of shares outstanding, with 2.42% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Shaw (Thomas J)
16.33M
+0.08%
Larios Michele Mitchell
861.00K
--
The Vanguard Group, Inc.
Star Investors
672.81K
-0.15%
Eversept Partners, LP
363.31K
--
Renaissance Technologies LLC
Star Investors
427.56K
+22.72%
BlackRock Institutional Trust Company, N.A.
241.12K
-1.64%
Geode Capital Management, L.L.C.
128.11K
--
Bridgeway Capital Management, LLC
88.54K
-43.11%
Laterza (Marco)
85.00K
--
Bigby (Walter O Jr)
80.00K
--
1
2

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Retractable Technologies Inc is 2.69, ranking 147 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.26. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Retractable Technologies Inc’s latest ESG disclosure lags behind the Healthcare Equipment & Supplies industry average, suggesting potential exposures in governance structure, environmental management, or social responsibility that may amplify risk and warrant ongoing monitoring.

Score

Industry at a Glance

Previous score
2.69
Change
0
Beta vs S&P 500 index
1.21
VaR
+5.53%
240-Day Maximum Drawdown
+38.68%
240-Day Volatility
+72.45%

Return

Best Daily Return
60 days
+7.72%
120 days
+11.94%
5 years
+14.41%
Worst Daily Return
60 days
-8.48%
120 days
-8.48%
5 years
-13.33%
Sharpe Ratio
60 days
-1.46
120 days
-0.78
5 years
-0.93

Risk Assessment

Maximum Drawdown
240 days
+38.68%
3 years
+59.79%
5 years
+95.75%
Return-to-Drawdown Ratio
240 days
-0.04
3 years
-0.29
5 years
-0.20
Skewness
240 days
+0.06
3 years
-0.13
5 years
-0.11

Volatility

Realised Volatility
240 days
+72.45%
5 years
+65.54%
Standardised True Range
240 days
+6.31%
5 years
+22.36%
Downside Risk-Adjusted Return
120 days
-125.95%
240 days
-125.95%
Maximum Daily Upside Volatility
60 days
+42.33%
Maximum Daily Downside Volatility
60 days
+37.91%

Liquidity

Average Turnover Rate
60 days
+0.20%
120 days
+0.17%
5 years
--
Turnover Deviation
20 days
+17.23%
60 days
-21.66%
120 days
-31.50%

Peer Comparison

Healthcare Equipment & Supplies
Retractable Technologies Inc
Retractable Technologies Inc
RVP
4.52 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bioventus Inc
Bioventus Inc
BVS
8.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.07 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.05 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI